| __timestamp | ADMA Biologics, Inc. | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 9517014 | 14182353 |
| Thursday, January 1, 2015 | 7015946 | 15503028 |
| Friday, January 1, 2016 | 7688238 | 16183585 |
| Sunday, January 1, 2017 | 6229587 | 22382849 |
| Monday, January 1, 2018 | 3926120 | 33038206 |
| Tuesday, January 1, 2019 | 2343848 | 31777040 |
| Wednesday, January 1, 2020 | 5907013 | 41464134 |
| Friday, January 1, 2021 | 3646060 | 67178053 |
| Saturday, January 1, 2022 | 3613764 | 52531000 |
| Sunday, January 1, 2023 | 3300000 | 68914000 |
Data in motion
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Pharming Group N.V. and ADMA Biologics, Inc. have demonstrated contrasting strategies in their R&D investments.
Pharming Group N.V. has consistently increased its R&D spending, peaking in 2023 with a remarkable 386% increase from 2014. This strategic focus underscores their commitment to pioneering advancements in the biotech sector.
Conversely, ADMA Biologics, Inc. has shown a more conservative R&D trajectory, with a 65% decrease in spending from 2014 to 2023. This cautious approach may reflect a focus on optimizing existing products rather than expanding their research portfolio.
These divergent strategies highlight the varied paths companies can take in the pursuit of innovation and market leadership.
Comparing Innovation Spending: Merck & Co., Inc. and ADMA Biologics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for argenx SE and ADMA Biologics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ADMA Biologics, Inc.
R&D Insights: How Bio-Techne Corporation and ADMA Biologics, Inc. Allocate Funds
Research and Development Investment: Pharming Group N.V. vs Alkermes plc
R&D Insights: How Pharming Group N.V. and Corcept Therapeutics Incorporated Allocate Funds
R&D Insights: How Pharming Group N.V. and MannKind Corporation Allocate Funds
R&D Spending Showdown: Pharming Group N.V. vs Dynavax Technologies Corporation
Research and Development Expenses Breakdown: Ionis Pharmaceuticals, Inc. vs ADMA Biologics, Inc.
Research and Development: Comparing Key Metrics for TG Therapeutics, Inc. and ADMA Biologics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for ADMA Biologics, Inc. and Iovance Biotherapeutics, Inc.
Research and Development: Comparing Key Metrics for ADMA Biologics, Inc. and Viridian Therapeutics, Inc.